In vitro cytotoxicity assays

TY Tara M. Young
CR Claudia Reyes
EP Elizabeth Pasnikowski
CC Carla Castanaro
CW Chung Wong
CD Corinne E. Decker
JC Joyce Chiu
HS Hang Song
YW Yi Wei
YB Yu Bai
BZ Brian Zambrowicz
GT Gavin Thurston
CD Christopher Daly
request Request a Protocol
ask Ask a question
Favorite

MC38 cells were seeded at 34,000 cells per 24 well and pulsed with Ova (1 ng/ml) or scrambled peptide 24 hours after seeding. Pulsed cells were cultured with activated CD8+ T cells at the indicated E:T ratios. After 24 hours, nonadherent tumor cells were washed away with PBS and cell viability was assessed. Where indicated, a neutralizing TNFα antibody or isotype control antibody was added at concentrations of 10 or 20 μg/ml.

Human ZR-75-1 cells were seeded at 100,000 cells per 24 well. After 24 hours, cells were incubated with T cells (isolated from human PBMCs) at the indicated E:T ratios for 24 hours in the presence of CD3 bispecific antibodies (12 ng/ml) (control or antitumor antigen) in the absence or presence of 5 μM autophagy inhibitor SAR405.

The effects of TNFα, TRAIL, doxorubicin, or paclitaxel on cell viability were assessed after 24-hour incubations at the indicated concentrations. The effects of 5 μM autophinib or SAR405 on TNFα (10 ng/ml)– or TRAIL (10 or 50 ng/ml)–induced killing were assessed after 24-hour incubations unless otherwise indicated. In all cases, cell viability was measured using cell counting kit-8 (CCK-8) reagent, which is reduced by dehydrogenase activities in cells to give a yellow-colored formazan dye (Dojindo). The absorbance was measured using a SpectraMax M3 microplate reader (Molecular Devices).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A